Replimune (REPL) Non Operating Income (2017 - 2025)
Replimune's (REPL) quarterly Non Operating Income came in at -$580000.0 in Q4 2025, down 328.35% year-on-year from $254000.0 in Q4 2024, and up 33.79% quarter-over-quarter from -$876000.0 in Q3 2025.
Replimune (REPL) Non Operating Income (2017 - 2025) Analysis & Trends
Replimune has disclosed Non Operating Income across 9 years of filings, most recently posting -$580000.0 for Q4 2025.
- Non Operating Income for Q4 2025 came in at -$580000.0, down 328.35% year-over-year; the trailing twelve-month figure through Dec 2025 was -$217000.0 (down 100.88% YoY), and the FY2025 annual result was -$202000.0, down 101.04% from the prior year.
- Non Operating Income came in at -$580000.0 for Q4 2025 at Replimune, up from -$876000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $18.1 million in Q1 2024 to a low of -$8.6 million in Q4 2023.
- The 5-year median for Non Operating Income is $115500.0 (2021), against an average of $990350.0.
- Across the five-year window, Non Operating Income slumped 5931.97% in 2023 and surged 1679.04% in 2024, its largest moves.
- Replimune's Non Operating Income stood at $24000.0 in 2021, then surged by 512.5% to $147000.0 in 2022, then plunged by 5931.97% to -$8.6 million in 2023, then surged by 102.96% to $254000.0 in 2024, then plunged by 328.35% to -$580000.0 in 2025.
- The last three Non Operating Income figures came in at -$580000.0 (Q4 2025), -$876000.0 (Q3 2025), and $591000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 9.35 Mn |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | -580,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -580,000.00 |
| Sep 30, 2025 | -876,000.00 |
| Jun 30, 2025 | 591,000.00 |
| Mar 31, 2025 | 648,000.00 |
| Dec 31, 2024 | 254,000.00 |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 406,000.00 |
| Mar 31, 2024 | 18.08 Mn |
| Dec 31, 2023 | -8.57 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | -1.15 Mn |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | -2.66 Mn |
| Jun 30, 2022 | -2.02 Mn |
| Mar 31, 2022 | 292,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | -356,000.00 |
| Jun 30, 2021 | -252,000.00 |
| Mar 31, 2021 | 84,000.00 |